| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5892036 | Bone | 2011 | 6 Pages |
Abstract
⺠Bisphosphonates are an integral part of treatment for patients with bone metastases from solid tumours and in multiple myeloma.⺠Prevention of skeletal morbidity with bisphosphonates has transformed the quality of life of patients with bone metastases. ⺠Bisphosphonates prevent bone loss associated with cancer treatments. However, selection criteria for intervention require further definition. ⺠Adjuvant use of bisphosphonates in early breast cancer may modify the disease course.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Robert E. Coleman, Eugene V. McCloskey,